Peter Kelley

Daptomycin non-susceptibility in vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous-VISA (hVISA): implications for therapy after vancomycin treatment failure

Peter Kelley, Wei Gao, Peter Ward et al. · Journal of Antimicrobial Chemotherapy · 2011 · 100 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +13

Immunogenicity and safety of Advax™, a novel polysaccharide adjuvant based on delta inulin, when formulated with hepatitis B surface antigen: A randomized controlled Phase 1 study

David Gordon, Peter Kelley, Susanne Heinzel et al. · Vaccine · 2014 · 92 citations

Pharmacy, Immunology, Pharmaceutics +17

The impact of a multidisciplinary antimicrobial stewardship team on the timeliness of antimicrobial therapy in patients with positive blood cultures: a randomized controlled trial

Kelly A. Cairns, Joseph Doyle, Janine M. Trevillyan et al. · Journal of Antimicrobial Chemotherapy · 2016 · 67 citations · Full text

Pharmacy, Infectious Diseases, Microbiology +17

The location of Australian Buruli ulcer lesions—Implications for unravelling disease transmission

Arvind Yerramilli, Ee Laine Tay, Andrew J. Stewardson et al. · PLoS neglected tropical diseases · 2017 · 63 citations · Full text

Veterinary Medicine, Dermatology, Infectious Diseases +15

Comparison of the Xpert Methicillin-Resistant <i>Staphylococcus aureus</i> (MRSA) Assay, BD GeneOhm MRSA Assay, and Culture for Detection of Nasal and Cutaneous Groin Colonization by MRSA

Peter Kelley, Elizabeth A. Grabsch, Benjamin P. Howden et al. · Journal of Clinical Microbiology · 2009 · 44 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +13